Cagril AM833
Cagrilintide is a long-acting analogue of amylin. It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide.
For research purposes only, not intended for human consumption. Comes in a lyophilized powder and will need to be reconstituted.
Cagrilintide is a long-acting analogue of amylin. It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide.
For research purposes only, not intended for human consumption. Comes in a lyophilized powder and will need to be reconstituted.
Cagrilintide is a long-acting analogue of amylin. It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide.
For research purposes only, not intended for human consumption. Comes in a lyophilized powder and will need to be reconstituted.
For research purpose only, not intended for human consumption. Comes in a lyophilized powder and will need to be reconstituted. All sales are final. No exchanges or returns allowed.